Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity
- PMID: 18327995
- DOI: 10.1586/14779072.6.3.343
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity
Abstract
When caloric intake exceeds caloric expenditure, the positive caloric balance and storage of energy in adipose tissue often causes adipocyte hypertrophy and visceral adipose tissue accumulation. These pathogenic anatomic abnormalities may incite metabolic and immune responses that promote Type 2 diabetes mellitus, hypertension and dyslipidemia. These are the most common metabolic diseases managed by clinicians and are all major cardiovascular disease risk factors. 'Disease' is traditionally characterized as anatomic and physiologic abnormalities of an organ or organ system that contributes to adverse health consequences. Using this definition, pathogenic adipose tissue is no less a disease than diseases of other body organs. This review describes the consequences of pathogenic fat cell hypertrophy and visceral adiposity, emphasizing the mechanistic contributions of genetic and environmental predispositions, adipogenesis, fat storage, free fatty acid metabolism, adipocyte factors and inflammation. Appreciating the full pathogenic potential of adipose tissue requires an integrated perspective, recognizing the importance of 'cross-talk' and interactions between adipose tissue and other body systems. Thus, the adverse metabolic consequences that accompany fat cell hypertrophy and visceral adiposity are best viewed as a pathologic partnership between the pathogenic potential adipose tissue and the inherited or acquired limitations and/or impairments of other body organs. A better understanding of the physiological and pathological interplay of pathogenic adipose tissue with other organs and organ systems may assist in developing better strategies in treating metabolic disease and reducing cardiovascular disease risk.
Similar articles
-
Adipose tissue dysfunction in obesity.Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Exp Clin Endocrinol Diabetes. 2009. PMID: 19358089 Review.
-
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Expert Rev Cardiovasc Ther. 2006 Nov;4(6):871-95. doi: 10.1586/14779072.4.6.871. Expert Rev Cardiovasc Ther. 2006. PMID: 17173503 Review.
-
Metabolic implications of dietary trans-fatty acids.Obesity (Silver Spring). 2009 Jun;17(6):1200-7. doi: 10.1038/oby.2008.662. Epub 2009 Feb 19. Obesity (Silver Spring). 2009. PMID: 19584878
-
Adiposopathy is "sick fat" a cardiovascular disease?J Am Coll Cardiol. 2011 Jun 21;57(25):2461-73. doi: 10.1016/j.jacc.2011.02.038. J Am Coll Cardiol. 2011. PMID: 21679848
-
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.Obesity (Silver Spring). 2006 Feb;14 Suppl 1:20S-24S. doi: 10.1038/oby.2006.278. Obesity (Silver Spring). 2006. PMID: 16642959 Review.
Cited by
-
Relationship Between Measures of Adiposity, Arterial Inflammation, and Subsequent Cardiovascular Events.Circ Cardiovasc Imaging. 2016 Apr;9(4):e004043. doi: 10.1161/CIRCIMAGING.115.004043. Circ Cardiovasc Imaging. 2016. PMID: 27072302 Free PMC article.
-
Association of longitudinal risk profile trajectory clusters with adipose tissue depots measured by magnetic resonance imaging.Sci Rep. 2019 Nov 18;9(1):16972. doi: 10.1038/s41598-019-53546-y. Sci Rep. 2019. PMID: 31740739 Free PMC article.
-
Ishige okamurae Extract Suppresses Obesity and Hepatic Steatosis in High Fat Diet-Induced Obese Mice.Nutrients. 2018 Nov 20;10(11):1802. doi: 10.3390/nu10111802. Nutrients. 2018. PMID: 30463291 Free PMC article.
-
Gold nanoparticles as cell regulators: beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity.J Nanobiotechnology. 2018 Nov 3;16(1):88. doi: 10.1186/s12951-018-0414-6. J Nanobiotechnology. 2018. PMID: 30390669 Free PMC article.
-
Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.Curr Atheroscler Rep. 2014 May;16(5):409. doi: 10.1007/s11883-014-0409-1. Curr Atheroscler Rep. 2014. PMID: 24659222 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical